---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-308144"
form_type: "8-K"
ticker: "KMTS"
cik: "0001877184"
company_name: "KESTRA MEDICAL TECHNOLOGIES, LTD."
filed_at: "2025-12-04T23:59:59+00:00"
generated_at: "2026-05-16T14:55:09.691562+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kestra Medical closes $148.4M public offering of 6.9M shares at $23.00

## Summary
- Offered 6,900,000 common shares at $23.00 per share, including full exercise of underwriters' over-allotment option of 900,000 shares.
- Net proceeds of approximately $148.4 million after underwriting discounts and estimated offering expenses.
- Proceeds to support sales/marketing, commercialization, R&D, clinical studies, and working capital.
- Underwriters included BofA Securities, Piper Sandler, J.P. Morgan, and Goldman Sachs; offering closed December 4, 2025.

## SEC filing metadata
- accession: 0001193125-25-308144
- form_type: 8-K
- ticker: KMTS
- cik: 0001877184
- company_name: KESTRA MEDICAL TECHNOLOGIES, LTD.
- filed_at: 2025-12-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1877184/000119312525308144/0001193125-25-308144-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1877184/000119312525308144/d92377d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-308144
- JSON: https://secwatch.observer/filing/0001193125-25-308144.json
- Plain text: https://secwatch.observer/filing/0001193125-25-308144.txt

## Key facts
- Material Agreements
  KESTRA MEDICAL TECHNOLOGIES, LTD. entered into Underwriting Agreement with BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein valued at approximately $148.4 million (effective 2025-12-02).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein
  - Value: approximately $148.4 million
  - Effective: 2025-12-02
  source text: On December 2, 2025, Kestra Medical Technologies, Ltd., a Bermuda exempted company (the “ Company ”) entered into an Underwriting Agreement (the “ Underwriting Agreement ”) with BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein (collectively, the “ Underwriters ”), related to an underwritten public offering (the “ Offering ”) of 6,900,000 common shares, par value $1.00 per share (the “ Common Shares ”), at a purchase price per share of $23.00 (the “ Offering Price ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1877184/000119312525308144/0001193125-25-308144-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.